Thus, it is possible that cGAS-STING stimulation contributes to antitumor immunity in both tumor and host immune cells indicating that TREX1, cGAS, and STING are candidate targets to modulate antitumor immunity. The gene discussed is TREX1; the disease is neoplasm.